Glucagon‐like peptide‐1 receptor agonists in pediatric metabolic dysfunction‐associated steatotic liver disease
This is the largest pediatric study on GLP-1RAs in MASLD to date. On a GLP-1RA, ALT significantly improved at 6 months and EOT, suggesting their role in improving disease activity. This should thus be considered as an adjunct to lifestyle modification in treating pediatric MASLD.
Authors
- Jennifer A. Panganiban (ORCID: https://orcid.org/0009-0001-5220-668X)
- Andrea M. Tou (ORCID: https://orcid.org/0009-0000-2001-6825)
Institutions
- Children's Hospital of Philadelphia (US)
Publication Details
- Journal
- Journal of Pediatric Gastroenterology and Nutrition
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1002/jpn3.70242
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Children's Hospital of Philadelphia